🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals said the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed violative content and banned associated keywords and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also discovered communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within minutes of joining one community, a vendor posted contact information, where most purchases occur. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Information and Costs

Within these communities, messages display black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for Telegram stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly significant medical dangers”.